Medication and Fall Prevention

1
Medication and Fall Prevention

• Presented by Susan Beresford BSCPharm

2
Objectives

• Role of Pharmacists
• Increase awareness of resources (MRP)
• Impact of Medications
• Community Resources lets connect the dots!

3
Role of Pharmacist

• Educate client on
• ? chronic conditions and lifestyle
  modification
• ? review medications
• ? partner in the management of clients health
• Be aware of Red Flags
• ? type of medication / chronic condition
• ? clients use of mobility device
• ? any vision issues

4
Medication Review Program

• At KINBURN PHARMASAVE

5
Objectives of the MRP

• ID and address Drug Related Problems (DRP)
• ID problems that a PhC cannot address and guide
  patients to seek help with another health
  professional
• Give patients guidance in resolving their
  presenting problems.
• Arrange for ongoing care.
• Reinforcement and follow up on proper medication
  use.

6
Physician Involvement in MRP

• Participation is voluntary and unfunded.
• Can recommend a patient for the service.
• Pharmacist will contact you to tell you of an
  enrolled patient. (FAX?)
• Pharmacist will consult with you before any
  recommendations are made impacting on a
  prescription medicine.
• All recommendations will be sent to you in a
  timely manner. ( education, compliance issues,
  training)

7
Types of Recommendations

• Type of recommendations will vary patient to
  patient.
• Appropriate OTC / Natural / Herbal use
• Education / tools to improve daily management of
  medications.
• Pharmacist will not independently make any
  recommendations on a prescription medication.

8
Eligible Patients

• MSI
• Patient must agree to MRP.
• Not Nursing home or blister pack patient.
• Taking 4 or more medicines OR a medication that
  potentially puts them at risk.
• Have at least one of the following diseases-
  asthma, arthritis, diabetes, congestive heart
  failure, chronic obstructive lung disease,
  hyperlipidemia or hypertension.

9
Patients Who Would Benefit

• Patients having trouble managing their
  medications.
• Patients who have had significant changes made to
  their drug regimen in the past 100 days.
• Patients on meds that require monitoring or
  follow up.
• Patients recently discharged from hospital.

10
What Patients Receive

• Initial private consultation with a Pharmacist
  lasting between 45 to 60 minutes.
• Complete updated list of medications, including
  over the counter medications and supplements.
• Review of the patients understanding and usage
  of their medications.
• Follow up with a Pharmacist that would include
  possible interventions to improve patients
  medication management and promote health.

11
References

• Medication Review Program sponsored by the
  Pharmacy Association of Nova Scotia and supported
  by MSI
• Pharmasave Medication Review Program

12
Impact of Medications

• Dizziness / confusion
• Light headedness
• Slowed reaction time
• Decreased awareness of surroundings
• Blurred vision
• Decrease in Blood Pressure
• BUT WHICH ONES AFFECT YOU AS AN INDIVIDUAL?

13
Planning

• TEAM UP
• Daytime
• Community Centres, Nursing Homes, Sponsoring
  groups offices, Special events
• Advertise
• Involve the community announce in churches,
  other community groups than the sponsor group.
• Have a weather date
• Have a healthy snack for the break if two 1
  hour sections to the presentation

14
Presenting in the Community

• Welcome, acknowledge the team
• Keep it informal
• Expectations
• Parking lot
• Try to keep the topic / information general, not
  patient specific information Please speak to
  YOUR Pharmacist
• Emphasize the importance of having one pharmacy
  let people know what we can do for them when we
  have all the information
• Thank all participants, team

15
References

• Safe Medicines for Seniors a Workshop for
  Caregivers, The Canadian Healthcare Association,
  Ottawa, 2006
• www.phac-aspc.gc.ca/seniors-aines/publications/pub
  lic/injury-blessure/pathways-voie/section2-eng.php
  
• www.phac-aspc.gc.ca/seniors-aines/publications/pub
  lic/injury-blessure/pathways-voie/section1-eng.php